Dec 6, 2017

Celgene Launches Celgene Cancer Care Links TM to Support Cancer Healthcare Capacity Building in Resource-Constrained Countries

Grant Program Will Help Fund Cancer Care Capability, Delivery and Access Programs

SUMMIT, NJ, December 5, 2017 – Celgene Corporation (NASDAQ:CELG) today announced the launch of Celgene Cancer Care Links, a new grant program designed to support cancer healthcare capacity building in resource-constrained countries around the world. As part of this program, Celgene will collaborate with medical centers focused on enhancing patient care and building sustainable cancer care systems in resourceconstrained countries. Funding will be provided to approved programs in 2018. Read More
Sep 25, 2017

Access Accelerated Brings Together Leaders to Discuss NCD Solutions During UNGA Week

To a standing-room only audience atop McCann Worldgroup headquarters in New York City, Access Accelerated hosted a special UN General Assembly side event with multisector leaders working to tackle non-communicable diseases around the world. The event began with an interactive marketplace where nine Access Accelerated member companies–Astellas, Bristol-Myers Squibb, Eisai, Merck KGaA, Pfizer, Roche, Sanofi, Shionogi and Daiichi-Sankyo–showcased NCD access programs that address the deadliest NCDs like cancer, diabetes and heart disease.

Read More